Anti-HER2 scFv antibody-directed lentiviral delivery of myrosinase for eradicating HER2+cancer cells after dosing prodrug sinigrin

被引：0
|
作者：
Tarar, Ammar Ahmad [1 ]
Peng, Ching-An [1 ]
机构：
[1] Univ Idaho, Moscow, ID 83843 USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3291
引用
收藏
页数：1
相关论文
共 50 条
  • [1] In situ delivery and production of anti-HER2 scFv
    Kikuchi, Takeshi
    Shimizu, Hitomi
    Akiyama, Yasuto
    Taniguchi, Shun'ichiro
    CANCER RESEARCH, 2015, 75
  • [2] Development of a Targeted anti-HER2 scFv Chimeric Peptide for Gene Delivery into HER2-Positive Breast Cancer Cells
    Cheraghi, Roya
    Nazari, Mahboobeh
    Alipour, Mohsen
    Majidi, Asia
    Hosseinkhani, Saman
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 515 (1-2) : 632 - 643
  • [3] Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells
    Sommaruga, Silvia
    Lombardi, Alessio
    Salvade, Agnese
    Mazzucchelli, Serena
    Corsi, Fabio
    Galeffi, Patrizia
    Tortora, Paolo
    Prosperi, Davide
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2011, 91 (03) : 613 - 621
  • [4] Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells
    Silvia Sommaruga
    Alessio Lombardi
    Agnese Salvadè
    Serena Mazzucchelli
    Fabio Corsi
    Patrizia Galeffi
    Paolo Tortora
    Davide Prosperi
    Applied Microbiology and Biotechnology, 2011, 91 : 613 - 621
  • [5] mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo
    Rybakova, Yulia
    Kowalski, Piotr S.
    Huang, Yuxuan
    Gonzalez, John T.
    Heartlein, Michael W.
    DeRosa, Frank
    Delcassian, Derfogail
    Anderson, Daniel G.
    MOLECULAR THERAPY, 2019, 27 (08) : 1415 - 1423
  • [6] Triple blockade of HER2 by a cocktail of anti-HER2 scFv antibodies induces high antiproliferative effects in breast cancer cells
    Nejatollahi, Foroogh
    Jaberipour, Mansooreh
    Asgharpour, Mahdi
    TUMOR BIOLOGY, 2014, 35 (08) : 7887 - 7895
  • [7] Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation
    Wang, Jing-Hung
    Forterre, Alexis V.
    Zhao, Jinjing
    Frimannsson, Daniel O.
    Delcayre, Alain
    Antes, Travis J.
    Efron, Bradley
    Jeffrey, Stefanie S.
    Pegram, Markd.
    Matin, A. C.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (05) : 1133 - 1142
  • [8] Conjugating MMAE to a novel anti-HER2 antibody for selective targeted delivery
    Li, L.
    Xu, M-Z
    Wang, L.
    Jiang, J.
    Dong, L-H
    Chen, F.
    Dong, K.
    Song, H-F
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (24) : 12929 - 12937
  • [9] Trastuzumab: Anti-HER2 antibody for treatment of metastatic breast cancer
    Wong, WM
    CANCER PRACTICE, 1999, 7 (01) : 48 - 50
  • [10] A case of metastatic breast cancer with outgrowth of HER2-negative cells after eradication of HER2-positive cells by humanized anti-HER2 monoclonal antibody (trastuzumab) combined with docetaxel
    Kunitomo, K
    Inoue, S
    Ichihara, F
    Kono, K
    Fujii, H
    Matsumoto, Y
    Ooi, A
    HUMAN PATHOLOGY, 2004, 35 (03) : 379 - 381
12345